Supplementary Figure S2 from Efficacy and Imaging-Enabled Pharmacodynamic Profiling of KRAS G12C Inhibitors in Xenograft and Genetically Engineered Mouse Models of Cancer Article Swipe
Catherine Lee
,
Ziyue Karen Jiang
,
Simon Planken
,
Lisa K. Manzuk
,
Roberto Ortiz
,
Michael Hall
,
Kavon Noorbehesht
,
Sripad Ram
,
Timothy Affolter
,
Gabriel E. Troche
,
Nathan T. Ihle
,
Theodore Johnson
,
Youngwook Ahn
,
Manfred Kraus
,
Anand Giddabasappa
·
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1158/1535-7163.30733968
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1158/1535-7163.30733968
Compound A modulates glucose metabolism and pERK signaling in MiaPaCa2 tumors after 3 days of treatment in the PET imaging cohort of animals
Related Topics
Concepts
Metadata
- Type
- article
- Landing Page
- https://doi.org/10.1158/1535-7163.30733968
- OA Status
- gold
- OpenAlex ID
- https://openalex.org/W7106787114
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W7106787114Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1158/1535-7163.30733968Digital Object Identifier
- Title
-
Supplementary Figure S2 from Efficacy and Imaging-Enabled Pharmacodynamic Profiling of KRAS G12C Inhibitors in Xenograft and Genetically Engineered Mouse Models of CancerWork title
- Type
-
articleOpenAlex work type
- Publication year
-
2025Year of publication
- Publication date
-
2025-11-27Full publication date if available
- Authors
-
Catherine Lee, Ziyue Karen Jiang, Simon Planken, Lisa K. Manzuk, Roberto Ortiz, Michael Hall, Kavon Noorbehesht, Sripad Ram, Timothy Affolter, Gabriel E. Troche, Nathan T. Ihle, Theodore Johnson, Youngwook Ahn, Manfred Kraus, Anand GiddabasappaList of authors in order
- Landing page
-
https://doi.org/10.1158/1535-7163.30733968Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1158/1535-7163.30733968Direct OA link when available
- Concepts
-
KRAS, Medicine, Cancer, Cancer research, Genetically engineered, Pharmacodynamics, Pharmacology, Profiling (computer programming), Cancer drugs, Pharmacokinetics, Cancer cell, Bioinformatics, Metabolism, Drug, Mutation, Synthetic lethalityTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
Full payload
| id | https://openalex.org/W7106787114 |
|---|---|
| doi | https://doi.org/10.1158/1535-7163.30733968 |
| ids.doi | https://doi.org/10.1158/1535-7163.30733968 |
| ids.openalex | https://openalex.org/W7106787114 |
| fwci | 0.0 |
| type | article |
| title | Supplementary Figure S2 from Efficacy and Imaging-Enabled Pharmacodynamic Profiling of KRAS G12C Inhibitors in Xenograft and Genetically Engineered Mouse Models of Cancer |
| biblio.issue | |
| biblio.volume | |
| biblio.last_page | |
| biblio.first_page | |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C2781187634 |
| concepts[0].level | 4 |
| concepts[0].score | 0.6885621547698975 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q20969980 |
| concepts[0].display_name | KRAS |
| concepts[1].id | https://openalex.org/C71924100 |
| concepts[1].level | 0 |
| concepts[1].score | 0.6566455960273743 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[1].display_name | Medicine |
| concepts[2].id | https://openalex.org/C121608353 |
| concepts[2].level | 2 |
| concepts[2].score | 0.6023414731025696 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q12078 |
| concepts[2].display_name | Cancer |
| concepts[3].id | https://openalex.org/C502942594 |
| concepts[3].level | 1 |
| concepts[3].score | 0.5926122665405273 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q3421914 |
| concepts[3].display_name | Cancer research |
| concepts[4].id | https://openalex.org/C3019111730 |
| concepts[4].level | 3 |
| concepts[4].score | 0.5723017454147339 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q159236 |
| concepts[4].display_name | Genetically engineered |
| concepts[5].id | https://openalex.org/C111113717 |
| concepts[5].level | 3 |
| concepts[5].score | 0.4608411490917206 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q725307 |
| concepts[5].display_name | Pharmacodynamics |
| concepts[6].id | https://openalex.org/C98274493 |
| concepts[6].level | 1 |
| concepts[6].score | 0.3679147958755493 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q128406 |
| concepts[6].display_name | Pharmacology |
| concepts[7].id | https://openalex.org/C187191949 |
| concepts[7].level | 2 |
| concepts[7].score | 0.34699150919914246 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q1138496 |
| concepts[7].display_name | Profiling (computer programming) |
| concepts[8].id | https://openalex.org/C3020340455 |
| concepts[8].level | 3 |
| concepts[8].score | 0.32903051376342773 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q974135 |
| concepts[8].display_name | Cancer drugs |
| concepts[9].id | https://openalex.org/C112705442 |
| concepts[9].level | 2 |
| concepts[9].score | 0.32067152857780457 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q323936 |
| concepts[9].display_name | Pharmacokinetics |
| concepts[10].id | https://openalex.org/C96232424 |
| concepts[10].level | 3 |
| concepts[10].score | 0.2999395728111267 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q4118072 |
| concepts[10].display_name | Cancer cell |
| concepts[11].id | https://openalex.org/C60644358 |
| concepts[11].level | 1 |
| concepts[11].score | 0.2968522906303406 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q128570 |
| concepts[11].display_name | Bioinformatics |
| concepts[12].id | https://openalex.org/C62231903 |
| concepts[12].level | 2 |
| concepts[12].score | 0.26056578755378723 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q1057 |
| concepts[12].display_name | Metabolism |
| concepts[13].id | https://openalex.org/C2780035454 |
| concepts[13].level | 2 |
| concepts[13].score | 0.2601521909236908 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q8386 |
| concepts[13].display_name | Drug |
| concepts[14].id | https://openalex.org/C501734568 |
| concepts[14].level | 3 |
| concepts[14].score | 0.2534503936767578 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q42918 |
| concepts[14].display_name | Mutation |
| concepts[15].id | https://openalex.org/C2778502085 |
| concepts[15].level | 4 |
| concepts[15].score | 0.2530752420425415 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q7662767 |
| concepts[15].display_name | Synthetic lethality |
| keywords[0].id | https://openalex.org/keywords/kras |
| keywords[0].score | 0.6885621547698975 |
| keywords[0].display_name | KRAS |
| keywords[1].id | https://openalex.org/keywords/cancer |
| keywords[1].score | 0.6023414731025696 |
| keywords[1].display_name | Cancer |
| keywords[2].id | https://openalex.org/keywords/genetically-engineered |
| keywords[2].score | 0.5723017454147339 |
| keywords[2].display_name | Genetically engineered |
| keywords[3].id | https://openalex.org/keywords/pharmacodynamics |
| keywords[3].score | 0.4608411490917206 |
| keywords[3].display_name | Pharmacodynamics |
| keywords[4].id | https://openalex.org/keywords/profiling |
| keywords[4].score | 0.34699150919914246 |
| keywords[4].display_name | Profiling (computer programming) |
| keywords[5].id | https://openalex.org/keywords/cancer-drugs |
| keywords[5].score | 0.32903051376342773 |
| keywords[5].display_name | Cancer drugs |
| language | |
| locations[0].id | doi:10.1158/1535-7163.30733968 |
| locations[0].is_oa | True |
| locations[0].source | |
| locations[0].license | cc-by |
| locations[0].pdf_url | |
| locations[0].version | acceptedVersion |
| locations[0].raw_type | posted-content |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | False |
| locations[0].raw_source_name | |
| locations[0].landing_page_url | https://doi.org/10.1158/1535-7163.30733968 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A2096595723 |
| authorships[0].author.orcid | https://orcid.org/0000-0001-5999-2452 |
| authorships[0].author.display_name | Catherine Lee |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Catherine Lee |
| authorships[0].is_corresponding | True |
| authorships[1].author.id | https://openalex.org/A2188542289 |
| authorships[1].author.orcid | https://orcid.org/0009-0007-4158-4689 |
| authorships[1].author.display_name | Ziyue Karen Jiang |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Ziyue Karen Jiang |
| authorships[1].is_corresponding | False |
| authorships[2].author.id | https://openalex.org/A2713411454 |
| authorships[2].author.orcid | https://orcid.org/0000-0001-8901-8992 |
| authorships[2].author.display_name | Simon Planken |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Simon Planken |
| authorships[2].is_corresponding | False |
| authorships[3].author.id | https://openalex.org/A4316246736 |
| authorships[3].author.orcid | https://orcid.org/0009-0002-0127-0339 |
| authorships[3].author.display_name | Lisa K. Manzuk |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Lisa K. Manzuk |
| authorships[3].is_corresponding | False |
| authorships[4].author.id | https://openalex.org/A2131614771 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-6578-1966 |
| authorships[4].author.display_name | Roberto Ortiz |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Roberto Ortiz |
| authorships[4].is_corresponding | False |
| authorships[5].author.id | https://openalex.org/A1959815153 |
| authorships[5].author.orcid | https://orcid.org/0000-0001-5652-5971 |
| authorships[5].author.display_name | Michael Hall |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Michael Hall |
| authorships[5].is_corresponding | False |
| authorships[6].author.id | https://openalex.org/A2416835883 |
| authorships[6].author.orcid | |
| authorships[6].author.display_name | Kavon Noorbehesht |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Kavon Noorbehesht |
| authorships[6].is_corresponding | False |
| authorships[7].author.id | https://openalex.org/A2132741038 |
| authorships[7].author.orcid | https://orcid.org/0000-0002-9770-106X |
| authorships[7].author.display_name | Sripad Ram |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Sripad Ram |
| authorships[7].is_corresponding | False |
| authorships[8].author.id | https://openalex.org/A1952862655 |
| authorships[8].author.orcid | |
| authorships[8].author.display_name | Timothy Affolter |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Timothy Affolter |
| authorships[8].is_corresponding | False |
| authorships[9].author.id | https://openalex.org/A4377305970 |
| authorships[9].author.orcid | https://orcid.org/0000-0003-4466-0732 |
| authorships[9].author.display_name | Gabriel E. Troche |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Gabriel E. Troche |
| authorships[9].is_corresponding | False |
| authorships[10].author.id | https://openalex.org/A2561376595 |
| authorships[10].author.orcid | https://orcid.org/0009-0006-2991-2742 |
| authorships[10].author.display_name | Nathan T. Ihle |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Nathan T. Ihle |
| authorships[10].is_corresponding | False |
| authorships[11].author.id | https://openalex.org/A2168523976 |
| authorships[11].author.orcid | https://orcid.org/0000-0002-8387-6192 |
| authorships[11].author.display_name | Theodore Johnson |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Theodore Johnson |
| authorships[11].is_corresponding | False |
| authorships[12].author.id | https://openalex.org/A2131182459 |
| authorships[12].author.orcid | https://orcid.org/0000-0001-5988-7388 |
| authorships[12].author.display_name | Youngwook Ahn |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | Youngwook Ahn |
| authorships[12].is_corresponding | False |
| authorships[13].author.id | https://openalex.org/A1784651053 |
| authorships[13].author.orcid | https://orcid.org/0000-0001-6668-6699 |
| authorships[13].author.display_name | Manfred Kraus |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | Manfred Kraus |
| authorships[13].is_corresponding | False |
| authorships[14].author.id | https://openalex.org/A2310667381 |
| authorships[14].author.orcid | https://orcid.org/0000-0002-1546-2481 |
| authorships[14].author.display_name | Anand Giddabasappa |
| authorships[14].author_position | last |
| authorships[14].raw_author_name | Anand Giddabasappa |
| authorships[14].is_corresponding | False |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.1158/1535-7163.30733968 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-11-28T00:00:00 |
| display_name | Supplementary Figure S2 from Efficacy and Imaging-Enabled Pharmacodynamic Profiling of KRAS G12C Inhibitors in Xenograft and Genetically Engineered Mouse Models of Cancer |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-28T02:12:24.556248 |
| primary_topic | |
| cited_by_count | 0 |
| locations_count | 1 |
| best_oa_location.id | doi:10.1158/1535-7163.30733968 |
| best_oa_location.is_oa | True |
| best_oa_location.source | |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | |
| best_oa_location.version | acceptedVersion |
| best_oa_location.raw_type | posted-content |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | |
| best_oa_location.landing_page_url | https://doi.org/10.1158/1535-7163.30733968 |
| primary_location.id | doi:10.1158/1535-7163.30733968 |
| primary_location.is_oa | True |
| primary_location.source | |
| primary_location.license | cc-by |
| primary_location.pdf_url | |
| primary_location.version | acceptedVersion |
| primary_location.raw_type | posted-content |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | False |
| primary_location.raw_source_name | |
| primary_location.landing_page_url | https://doi.org/10.1158/1535-7163.30733968 |
| publication_date | 2025-11-27 |
| publication_year | 2025 |
| referenced_works_count | 0 |
| abstract_inverted_index.3 | 12 |
| abstract_inverted_index.A | 1 |
| abstract_inverted_index.in | 8, 16 |
| abstract_inverted_index.of | 14, 21 |
| abstract_inverted_index.PET | 18 |
| abstract_inverted_index.and | 5 |
| abstract_inverted_index.the | 17 |
| abstract_inverted_index.days | 13 |
| abstract_inverted_index.pERK | 6 |
| abstract_inverted_index.after | 11 |
| abstract_inverted_index.cohort | 20 |
| abstract_inverted_index.tumors | 10 |
| abstract_inverted_index.glucose | 3 |
| abstract_inverted_index.imaging | 19 |
| abstract_inverted_index.MiaPaCa2 | 9 |
| abstract_inverted_index.modulates | 2 |
| abstract_inverted_index.signaling | 7 |
| abstract_inverted_index.treatment | 15 |
| abstract_inverted_index.metabolism | 4 |
| abstract_inverted_index.<p>Compound | 0 |
| abstract_inverted_index.animals</p> | 22 |
| cited_by_percentile_year | |
| countries_distinct_count | 0 |
| institutions_distinct_count | 15 |
| citation_normalized_percentile |